We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Google Contact Lens Could Monitor Glucose Levels

By LabMedica International staff writers
Posted on 29 Jan 2014
Google (Mountain View, CA, USA; www.google.com) has announced a smart contact lens that can detect glucose levels via the wearer’s tears, and alert them when levels dip or rise.

The smart contact lens is under development by Google[x], the company’s clandestine division dedicated to difficult, future-looking projects, which also developed Google Glass, the self-driving car, and internet balloons. More...
The lens is designed to work via a small wireless chip and glucose sensor embedded between two pieces of soft material. The technique used to measure glucose levels is called amperometric sensing, which involves measuring the changes in tiny currents between the two sets of electrodes. All the electronics and sensors are located outside the central area of the lens, to avoid interference with the wearer's vision.

The current prototype puts out a reading once a second. Google is also interested in integrating light emitting diodes (LEDs) into the lens, which could light up or flash to alert the wearer of dangerous glucose levels, and eventually overlay information directly onto the wearer's field of view. However, the small size of the contact lens means that the pixels will have to be much smaller than those in a typical computer monitor or mobile phone display in order to provide a similar resolution.

The motivation for the project, according to the project leaders, is that glucose levels change frequently with normal activity such as exercising, eating, or even sweating. Sudden spikes or precipitous drops are dangerous and not uncommon, requiring round-the-clock monitoring. Although, some people wear glucose monitors with a sensor embedded under their skin, all diabetics must still prick their finger and test drops of blood throughout the day, a disruptive, painful procedure that results in many people with diabetes checking their blood glucose less often than they should.

“It’s still early days for this technology, but we’ve completed multiple clinical research studies which are helping to refine our prototype. We hope this could someday lead to a new way for people with diabetes to manage their disease,” posted project co-founders Brian Otis, PhD, and Babak Parviz, PhD, in the official Google blog. “We’ve always said that we’d seek out projects that seem a bit speculative or strange, and at a time when the International Diabetes Federation is declaring that the world is “losing the battle” against diabetes, we thought this project was worth a shot.”

The first smart contact lens, called Triggerfish, was created by Sensimed (Lausanne, Switzerland), a spin-off of the Swiss Federal Institute of Technology. The wirelessly powered contact lens is designed to help people with glaucoma manage their treatment. It does this by continuously measuring the curvature of the eye over a 24-hour period using a strain gauge based on micro-electromechanical system (MEMS) technology, which is incorporated into the lens.

Related Links:

Google
Sensimed 



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.